Cheyenne Wyoming, May 17, 2016 (GLOBE NEWSWIRE) -- MedX Holdings, Inc. (OTC PINK: MEDH) today announces MedX is in the process of becoming licensed as a Wholesale Distributor of Pharmaceuticals in the state of Alabama. As a result, the company has also entered into an Exclusive Marketing Agreement with B&B Consulting whose sales exceeded over $7,000,000 dollars in pharmaceutical sales in 2015. Mr. Hiltz, Managing Member of B&B Consulting has agreed to oversee the company’s pharmaceutical sales division. Mr. Hiltz stated “I am excited to join MedX Holdings, I believe that the combination of a public company and pharmaceutical sales just makes sense.”
In addition, MedX has also secured an agreement with one of the largest FDA Manufacturers in the United States. Our first product that has been approved to sell is a 5% Lidocaine Ointment 50g jar. Our negotiated price allows us to have very competitive pricing to offer B&B’s current list of clients. 5% Lidocaine is a highly sought after analgesic ointment for the purpose of reducing and controlling pain. This comes at a time when our nation is riveting over the rising deaths occurring in epidemic proportion all resulting from the overuse of oral prescription pain medication. As a result, Physicians and other medical professionals are being forced to look at alternative solutions when treating pain.
Kathleen Roberton CEO of MedX Holdings stated, “It makes perfect sense to enter into Pharmaceutical and Nutraceutical sales as we build our portfolio of medial businesses. This will allow our company to produce its own revenue without being a burden to our acquisitions which add tangilble asset based value”.
MedX Holdings, Inc. is a publicly trading holding company utilizing a new form of collaborative governance to create added value for its portfolio of holdings. MEDH targets the acquisitions of undervalued, turnaround medical related businesses along with products and services that benefit our partners. Our mission is to provide a new form of governance enabling medical related businesses and product driven partners to take advantage of the power of a public company without losing management expertise.
For more information about MedX Holdings, Inc., call (877) 225-0243 or visit our web site www.medxholdings.com, the company is located at 1621 Central Avenue, Cheyenne, WY, USA
Safe-Harbor Statement under the Private Securities Litigation Reform Act of 1995: This press release may contain forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the Exchange Act), including all statements that are not statements of historical fact regarding the intent, belief or current expectations of the company, its directors or its officers with respect to, among other things: (i) the company’s financing plans; (ii) trends affecting the company’s financial condition or results of operations; (iii) the company’s growth strategy and operating strategy; and (iv) the declaration and payment of dividends. The words “may,” “would,” “will,” “expect,” “estimate,” “anticipate,” “believe,” “intend” and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company’s ability to control, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors including the risk disclosed in the company’s Annual and Quarterly reports filed with the OTC Markets.
